Literature DB >> 1355295

Effects of tizanidine on morphine physical dependence: attenuation and intensification.

H Koyuncuŏglu1, F Ariciŏglu, Y Uresin, Y Dizdar, Y Esin.   

Abstract

It has previously been shown that subchronic and acute administration of L-asparaginase and glutaminase inhibitors D-Aspartic acid (D-ASP) and prolyl-leucyl-glycinamide (PLG) intensifies and attenuates morphine (M) physical dependence, respectively, by the inhibition of ASP and glutamic acid (GLU) production, and subsequently their normal releases. Tizanidine (TIZ) has long been known to be an alpha 2-adrenoceptor agonist and inhibitor of ASP and GLU release. Therefore, in this study TIZ has been administered subchronically during the development of M physical dependence to rats in which M-containing pellets had been implanted or acutely 30 min before naloxone (NL)-induced abstinence syndrome. The subchronic administration of TIZ intensified NL-precipitated abstinence syndrome whereas its acute administration attenuated it, as did D-ASP and PLG. On the other hand, TIZ added into the medium prevented the in vitro M-dependent-made guinea pig ileum from contracting following NL application. Furthermore, TIZ stopped the already started contraction by NL of the M-dependent ileum, which completely relaxed later. These effects of TIZ on M-dependent ileum were antagonized by the alpha 2-adrenoceptor antagonist yohimbine. The intensification by subchronic TIZ administration of abstinence syndrome was attributed to the lesser release of ASP and GLU, which resulted in the larger blockade of M of ASPergic/GLUergic receptors due to the lesser release of their endogenous agonist ASP and GLU and consequently the higher upregulation of the receptors. The attenuation by acute TIZ administration of NL-precipitated abstinence syndrome was explained with lesser release of ASP and GLU and concomitantly the lesser stimulation of the receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355295     DOI: 10.1016/0091-3057(92)90016-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Neuroprotection by alpha 2-adrenergic agonists in cerebral ischemia.

Authors:  Yonghua Zhang; Harold K Kimelberg
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

Review 2.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

Review 3.  Glutamate and Brain Glutaminases in Drug Addiction.

Authors:  Javier Márquez; José A Campos-Sandoval; Ana Peñalver; José M Matés; Juan A Segura; Eduardo Blanco; Francisco J Alonso; Fernando Rodríguez de Fonseca
Journal:  Neurochem Res       Date:  2016-12-23       Impact factor: 3.996

4.  NrCAM-regulating neural systems and addiction-related behaviors.

Authors:  Hiroki Ishiguro; Frank S Hall; Yasue Horiuchi; Takeshi Sakurai; Akitoyo Hishimoto; Martin Grumet; George R Uhl; Emmanuel S Onaivi; Tadao Arinami
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

Review 5.  Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.

Authors:  A J Wagstaff; H M Bryson
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

6.  Tizanidine exerts anti-nociceptive effects in spared nerve injury model of neuropathic pain through inhibition of TLR4/NF-κB pathway.

Authors:  Wanmin Pei; Yi Zou; Wenting Wang; Lai Wei; Yuan Zhao; Li Li
Journal:  Int J Mol Med       Date:  2018-09-13       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.